Critical Review of Data in Follicular Lymphoma - a podcast by ReachMD

CME credits: 0.25

Valid until: 04-06-2022

Claim your CME credit at https://reachmd.com/programs/cme/critical-review-data-follicular-lymphoma/12625/

Follicular lymphoma (FL) is an incurable neoplasm that is frequently associated with relapse and refractory (R/R) disease. In this activity, Drs. Loretta Nastoupil and Gilles Salles will review the role of EZH2 modulation in FL and explain the role that EZH2 inhibition can play in R/R disease. They will also discuss the many available oral therapeutic options and emerging therapies on the horizon, recent data from those clinical trials, and where these therapies will fit into clinical practice.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD